Want Congressional bipartisanship? Talk about cutting drug prices!
Senate and House committees begin the legislative process for addressing drug pricing
Global pharma spending will hit $1.5 trillion in 2023, says IQVIA
Annual analysis predicts 3-6% CAGR through 2023, a lower rate than 2014-2018
Cellular and genetic therapies push into the commercial arena
Even as the science behind the new therapies is getting established, payers are preparing for their extraordinary cost
Savsu Technologies offers new CGT transport containers
Broader capabilities for refrigerated or cryogenic transport of cellular materials
ZappRx builds out more disease-specific prior-authorization programs
Signs up Bayer Health for pulmonary hypertension and MS
DSCSA compliance: Industry is still in the trenches
Nov. 27, 2018, was to be a red-letter day in the 10-year program to implement an end-to-end pharma traceability system. Did industry meet the deadline?
New PAP programs for HIV, migraine, bladder cancer and an enzyme deficiency
Programs provide copay and other financial assistance
Poseidon network advances its pharmaceutical ocean-freight initiative
Field trial results to be unveiled at upcoming meeting
Cryoport expands its sources of temperature-controlled logistics solutions
Partnership with Dacos A/S; FDA will look closer at cellular and genetic therapies
Dartmouth academics look at 20 years of medical marketing
Spending on drug promotion rose—but not at the rate of pharma sales growth
Prescription digital therapeutics are entering the healthcare mainstream
Sandoz and Pear Therapeutics tackle opioid use disorder
Antares Vision recapitalizes with a $80-million investment by Mediobanca
Strengthening a leading player in track-and-trace packaging technology
BMS offers $74 billion to acquire Celgene
A deeper commitment to oncology and immunology
FROM PRMA CONSULTING
FDA set an all-time record of new drug approvals in 2018
List includes 25 orphan drugs; there were also seven additional biosimilars
Here comes the 2018-19 US flu season
Flu activity is “elevated” nationally; Walgreens sees a hotspot in Nebraska
HIV/AIDS treatment: Improving the trajectory for all stakeholders
Nearly a million US citizens live with HIV, a virus that still lacks a curative therapy
The scramble to ramp up CGT production
Cellular and genetic therapies (CGTs) developers are struggling to build capacity
HDA Research Foundation releases specialty-pharmaceutical distribution report
Oncology represents half of the dollar volume of HDA-member sales
Clinical value translates into commercial success, finds Trinity Partners study
Pfizer’s Ibrance was the star performer from the class of 2015 FDA approvals
Kuehne + Nagel acquires Quick International, express courier for pharmaceuticals
Action consolidates leading courier companies with larger freight forwarders
HDA Foundation 2018-19 Factbook is released
Sales volume handled by primary wholesaler/distributors seems to be declining
SkyCell claims 99.9% on-spec performance in cold chain shipments
The carbon footprint of shipping alternatives is also becoming a competitive issue
Actelion Pharmaceuticals settles with DoJ over patient copay improprieties
$360-million settlement involved assistance funneled through a charity
There’s a new certification process for compounding pharmacies
HFAP builds out from its hospital-accreditation business
MACRA looms large in community oncologists’ practice perspectives
New Cardinal Health survey sees the profession adjusting to value-based care
Senderra Rx expands its specialty pharmacy network
Now a national provider, Senderra’s new dispensing location is in Morrisville, NC
GAO mostly okays FDA's approval process for rare disease designations
More-complete information is desirable on some applications
McKesson is relocating from San Francisco to the Dallas area
Already-built Las Colinas facility will be the global headquarters in April 2019
Patient service program are loosely monitored for regulatory compliance, says Helio Health
New survey finds weaknesses in patient privacy, funding oversight
